PTHS relationship map

PTHS

20 ties · extendedThe company

PTHS (Pelthos Therapeutics Inc.) has 11 disclosed suppliers and 9 disclosed customers, strongest disclosure first.

Suppliers:

  1. Ligand Pharmaceuticals, Inc. (LGND), +0.76% today
  2. Copper II 2020, LLC, off tape
  3. Ferrer, off tape
  4. Hatchtech Pty Ltd., off tape
  5. Interquim, off tape
  6. Orion Corporation ("Orion"), off tape
  7. University of North Carolina at Chapel Hill (UNC), off tape
  8. Biofrontera, Inc., off tape
  9. Ferrer Internacional S.A., off tape
  10. Interquim, S.A.U., off tape
  11. Ligand, off tape

Customers:

  1. Undisclosed wholesaler customer (35% of gross revenue), off tape
  2. Undisclosed wholesaler customer (35% of 2025 gross revenue), off tape
  3. Undisclosed wholesaler customer (28% of gross revenue), off tape
  4. Undisclosed wholesaler customer (28% of 2025 gross revenue), off tape
  5. Undisclosed wholesaler customer (26% of gross revenue), off tape
  6. Undisclosed wholesaler customer (26% of 2025 gross revenue), off tape
  7. Sato Pharmaceutical Co., Ltd., off tape
  8. Ligand Pharmaceuticals, Inc. (LGND), +0.76% today
  9. Amazon pharmacy (AMZN), 0.00% today
100%

Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Drag the map to pan. Extended: satellites hang off single companies, not bundled sectors.

Sign in to keep this map. A saved view records the company, how far it reaches and the sector you are reading, then draws it again against a live tape whenever you open it.

Sign in

Not investment advice. Varamir is not a brokerage and does not execute orders. Prices via Intrinio; the tape shows ETF proxies. The supply-chain graph is published under CC BY 4.0; licensed market data is not redistributable.